| The prevalence and incidence of neurocognitive impairment in the HAART era KR Robertson, M Smurzynski, TD Parsons, K Wu, RJ Bosch, J Wu, ... Aids 21 (14), 1915-1921, 2007 | 806 | 2007 |
| Colistin versus ceftazidime-avibactam in the treatment of infections due to carbapenem-resistant Enterobacteriaceae D Van Duin, JJ Lok, M Earley, E Cober, SS Richter, F Perez, RA Salata, ... Clinical Infectious Diseases 66 (2), 163-171, 2018 | 588 | 2018 |
| Ticagrelor versus aspirin in acute stroke or transient ischemic attack SC Johnston, P Amarenco, GW Albers, H Denison, JD Easton, SR Evans, ... New England Journal of Medicine 375 (1), 35-43, 2016 | 510 | 2016 |
| Ticagrelor and aspirin or aspirin alone in acute ischemic stroke or TIA SC Johnston, P Amarenco, H Denison, SR Evans, A Himmelmann, ... New England Journal of Medicine 383 (3), 207-217, 2020 | 447 | 2020 |
| Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance CM Marra, Y Zhao, DB Clifford, S Letendre, S Evans, K Henry, RJ Ellis, ... Aids 23 (11), 1359-1366, 2009 | 437 | 2009 |
| Impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals DB Clifford, S Evans, Y Yang, EP Acosta, K Goodkin, K Tashima, ... Annals of internal medicine 143 (10), 714-721, 2005 | 343 | 2005 |
| Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort M Smurzynski, K Wu, S Letendre, K Robertson, RJ Bosch, DB Clifford, ... Aids 25 (3), 357-365, 2011 | 266 | 2011 |
| Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort KR Robertson, Z Su, DM Margolis, A Krambrink, DV Havlir, S Evans, ... Neurology 74 (16), 1260-1266, 2010 | 264 | 2010 |
| Desirability of outcome ranking (DOOR) and response adjusted for duration of antibiotic risk (RADAR) SR Evans, D Rubin, D Follmann, G Pennello, WC Huskins, JH Powers, ... Clinical Infectious Diseases 61 (5), 800-806, 2015 | 254 | 2015 |
| Peripheral neuropathy in HIV: prevalence and risk factors SR Evans, RJ Ellis, H Chen, T Yeh, AJ Lee, G Schifitto, K Wu, RJ Bosch, ... Aids 25 (7), 919-928, 2011 | 237 | 2011 |
| Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality LJ Rojas, M Salim, E Cober, SS Richter, F Perez, RA Salata, RC Kalayjian, ... Clinical Infectious Diseases 64 (6), 711-718, 2017 | 230 | 2017 |
| Clinical trial structures SR Evans Journal of experimental stroke & translational medicine 3 (1), 8, 2010 | 227 | 2010 |
| HIV neuropathy natural history cohort study: assessment measures and risk factors DM Simpson, D Kitch, SR Evans, JC McArthur, DM Asmuth, B Cohen, ... Neurology 66 (11), 1679-1687, 2006 | 217 | 2006 |
| Measuring and testing for spatial synchrony JP Buonaccorsi, JS Elkinton, SR Evans, AM Liebhold Ecology 82 (6), 1668-1679, 2001 | 216 | 2001 |
| Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study D Van Duin, CA Arias, L Komarow, L Chen, BM Hanson, G Weston, ... The Lancet Infectious Diseases 20 (6), 731-741, 2020 | 212 | 2020 |
| Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double … P Amarenco, GW Albers, H Denison, JD Easton, SR Evans, P Held, ... The Lancet Neurology 16 (4), 301-310, 2017 | 212 | 2017 |
| Alternatives to hazard ratios for comparing the efficacy or safety of therapies in noninferiority studies H Uno, J Wittes, H Fu, SD Solomon, B Claggett, L Tian, T Cai, MA Pfeffer, ... Annals of internal medicine 163 (2), 127-134, 2015 | 207 | 2015 |
| Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in co-infected subjects RT Chung, SR Evans, Y Yang, D Theodore, H Valdez, R Clark, ... Aids 16 (14), 1915-1923, 2002 | 203 | 2002 |
| Effect of deutetrabenazine on chorea among patients with Huntington disease: a randomized clinical trial S Frank, CM Testa, D Stamler, E Kayson, C Davis, MC Edmondson, ... Jama 316 (1), 40-50, 2016 | 179 | 2016 |
| Surveillance of carbapenem-resistant Klebsiella pneumoniae: tracking molecular epidemiology and outcomes through a regional network D Van Duin, F Perez, SD Rudin, E Cober, J Hanrahan, J Ziegler, ... Antimicrobial agents and chemotherapy 58 (7), 4035-4041, 2014 | 171 | 2014 |
Toshimitsu HamasakiThe George Washington University Biostatistics CenterVerified email at gwu.edu
